ADAR1 Capital Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-70,419
| Closed | -$111K | – | 227 |
|
|
2025
Q1 | $111K | Buy |
+70,419
| New | +$111K | 0.02% | 156 |
|
|
2024
Q4 | – | Sell |
-152,865
| Closed | -$287K | – | 283 |
|
|
2024
Q3 | $287K | Sell |
152,865
-18,352
| -11% | -$34.5K | 0.05% | 136 |
|
|
2024
Q2 | $337K | Buy |
171,217
+61,126
| +56% | +$120K | 0.06% | 111 |
|
|
2024
Q1 | $338K | Buy |
+110,091
| New | +$338K | 0.08% | 90 |
|